John J. Orloff, M.D.
 
 
 

John J. Orloff

John J. Orloff, M.D.
Chief Medical Officer and Senior Vice President, Global Development
Novartis Pharmaceuticals

John J. Orloff, M.D. is the Chief Medical Officer and Senior Vice President, Global Development, for Novartis Pharmaceuticals.  In this position, Dr. Orloff is responsible for providing strategic and scientific leadership for all processes within Global Development, and for representing Novartis externally in various forums interfacing with the scientific, academic, and health policy communities.  In addition, Dr. Orloff serves as Chair of the Pharma Portfolio Stewardship Board (PSB), which oversees safety and risk management plans for products within Pharma.  Dr. Orloff has held a number of roles with increasing responsibility at Novartis, including Section Head for Bone Metabolism in Clinical Development, Vice President and Therapeutic Area Head of the Arthritis, Bone Metabolism, and Women’s Health division within Clinical Development and Medical Affairs, and most recently as Head of US Medical and Drug Regulatory Affairs.  Dr. Orloff graduated from Dartmouth College, received his medical degree from the University of Vermont, and completed specialty training in Endocrinology and Metabolism at Yale University, where he served on the faculty as an Associate Professor of Medicine before moving on to Merck Research Labs to lead clinical programs in bone metabolism.